Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Helsinn grants Gruppo Angelini's CSC Pharmaceuticals European anamorelin rights

Executive Summary

Swiss pharmaco Helsinn Group licensed Gruppo Angelini’s CSC Pharmaceuticals Handels GMBH exclusive commercialization rights in Austria, Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovak Republic, Georgia, Russia and other CIS territories to anamorelin for anorexia-cachexia syndrome related to non-small cell lung cancer.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies